Financial Data and Key Metrics Changes - Consolidated net sales from continuing operations for Q4 2024 were $459 million, up 4.3% year-over-year on an organic basis and 1.4% as reported [24] - Adjusted EBITDA from continuing operations was $44.8 million, down 10% from $50 million in the prior year, impacted by higher input and manufacturing costs [25][30] - Adjusted EBITDA margin increased slightly year-over-year in the SAS segment, while FAM's adjusted EBITDA was down more than $10 million year-over-year [26][27] Business Line Data and Key Metrics Changes - SAS segment net sales were $291 million, up almost 13% on an organic basis, driven by higher volumes across all end markets [25] - FAM segment net sales were $168 million, down more than 7% year-over-year, with stable performance in filtration but lower volumes in advanced films [27] - SAS generated strong adjusted EBITDA performance of $36 million, up almost 8% year-over-year, while FAM's adjusted EBITDA was $26 million [25][27] Market Data and Key Metrics Changes - The overall market demand remains challenged, impacting Q1 results, with expectations of higher inventory costs and input costs [32] - The company anticipates a $10 million to $15 million headwind on input costs mainly driven by increases in the price of pulp, papers, resins, and polymers [33] Company Strategy and Development Direction - The company is focused on profit growth, cash flow generation, and reducing debt and leverage, with plans to reduce overall capital spending while still investing for growth [21][22] - A clear portfolio strategy has been established with identified growth platforms and investments aligned with the strongest markets and customers [21] - The company has restructured its organization, reducing non-operating costs by over $20 million in 2024, with plans for an additional $20 million reduction by the end of 2026 [19] Management's Comments on Operating Environment and Future Outlook - Management acknowledged a prolonged low industrial demand environment and is optimistic about leveraging commercial excellence best practices across the company [22][23] - The company is executing initiatives to deliver a more agile operating model and grow share in current markets while expanding addressable markets [35] - Management expressed confidence in the turnaround efforts in the FAM segment, particularly in advanced films, and expects improvements in the second half of the year [58] Other Important Information - The company has reduced its debt by over 35% and streamlined its plant footprint by over 25% [19] - A new leadership structure has been implemented to drive improvements across the business, with Ryan Elwart promoted to lead commercial activities [20] Q&A Session Summary Question: Impact of higher inventory and input costs on Q1 - Management confirmed that Q1 will be impacted by higher inventory and input costs, with plans in place to cover these through pricing actions over the year [38][39] Question: Strategy regarding potential tariffs in Canada and Mexico - Management indicated that there has been minimal impact from implemented tariffs and has plans to mitigate potential future tariffs through supply chain adjustments [41][42] Question: Leveraging SAS successes in FAM - Management outlined four key areas for leveraging SAS successes in FAM, including demand generation, strategic customer management, cross-selling opportunities, and leveraging talent across segments [49][50] Question: Sustainability of healthcare turnaround - Management expressed confidence in the sustainability of the healthcare turnaround, highlighting strong growth and margin improvements [54][56] Question: Progress on previous investments in new lines - Management provided updates on various investments, noting that while some are still in early stages, they are confident in the growth potential despite reducing CapEx spending [60][61]

Company Performance - Mativ Holdings reported quarterly earnings of $0.05 per share, exceeding the Zacks Consensus Estimate of $0.04 per share, but down from $0.23 per share a year ago, representing a 25% earnings surprise [1] - The company posted revenues of $458.6 million for the quarter ended December 2024, missing the Zacks Consensus Estimate by 3.17%, and showing a slight increase from $452.3 million year-over-year [2] - Over the last four quarters, Mativ Holdings has surpassed consensus EPS estimates two times and topped consensus revenue estimates just once [2] Market Performance - Mativ Holdings shares have declined approximately 17% since the beginning of the year, contrasting with the S&P 500's gain of 4.2% [3] - The current consensus EPS estimate for the upcoming quarter is $0.17 on revenues of $485.6 million, and for the current fiscal year, it is $1.15 on revenues of $2.01 billion [7] Industry Outlook - The Chemical - Specialty industry, to which Mativ Holdings belongs, is currently ranked in the bottom 19% of over 250 Zacks industries, indicating potential challenges ahead [8] - The performance of Mativ Holdings may be influenced by the overall outlook for the industry, as research indicates that the top 50% of Zacks-ranked industries outperform the bottom 50% by more than 2 to 1 [8]

Exhibit 99.1 Mativ Announces Fourth Quarter and Full Year 2024 Results ALPHARETTA, GA, February 19, 2025 -– Mativ Holdings, Inc. ("Mativ" or the "Company") (NYSE: MATV) reported earnings results for the three months and year ended December 31, 2024. On November 30, 2023, Mativ Holdings, Inc. ("Mativ" or the "Company") completed the sale of its Engineered Papers business. Financial results for continuing operations exclude Engineered Papers in all periods. Adjusted measures are reconciled to GAAP at the end ...

Mativ Holdings, Inc. (MATV) , the manufacturer of Argotec interlayer films for high-performance glazing, and Chasm Advanced Materials, Inc. (“CHASM”) have signed an exclusive licensing deal. Under the agreement, CHASM's AgeNT Silver Nanowire (AgNW) and Carbon Nanotube (CNT) hybrid performance film technology will be licensed to Mativ for transparent heating solutions in advanced glass and window applications in the architectural, military and transportation segments.This deal is another milestone in Mativ a ...

Mativ Holdings (MATV) came out with quarterly earnings of $0.21 per share, missing the Zacks Consensus Estimate of $0.26 per share. This compares to earnings of $0.21 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -19.23%. A quarter ago, it was expected that this paper and reconstituted tobacco company would post earnings of $0.21 per share when it actually produced earnings of $0.34, delivering a surprise of 61.90%.Over the ...

Exhibit 99.1 Mativ Announces Third Quarter 2024 Results ALPHARETTA, GA, November 6, 2024 -– Mativ Holdings, Inc. ("Mativ" or the "Company") (NYSE: MATV) reported earnings results for the three months ended September 30, 2024. On November 30, 2023, Mativ Holdings, Inc. ("Mativ" or the "Company") completed the sale of its Engineered Papers business. Financial results for continuing operations exclude Engineered Papers in all periods. Adjusted measures are reconciled to GAAP at the end of this release. Financi ...

Mativ Holdings (MATV) shares ended the last trading session 5.7% higher at $16.85. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 5.9% loss over the past four weeks. For Mativ Holdings, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an ey ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from __________________to __________________ 1-13948 (Commission file number) MATIV HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 62-1612879 (State or other jurisdiction of incorporation or organization) ☒ For the quarterly period ended March 31, 2024 100 Kimball P ...

Exhibit 99.1 Mativ Announces First Quarter 2024 Results ALPHARETTA, GA, May 8, 2024 -– Mativ Holdings, Inc. ("Mativ" or the "Company") (NYSE: MATV) reported earnings results for the three months ended March 31, 2024. On November 30, 2023, Mativ Holdings, Inc. ("Mativ" or the "Company") completed the sale of its Engineered Papers business. Financial results for continuing operations exclude Engineered Papers in all periods. Adjusted measures are reconciled to GAAP at the end of this release. Financial compar ...

Investors looking for stocks in the Chemical - Specialty sector might want to consider either Mativ Holdings (MATV) or Novozymes A/S (NVZMY) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.The best way to find great value stocks is to pair a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system. The Zacks Rank is a proven strategy that targets companies with positive earnings estimate revisi ...